Detalhe da pesquisa
1.
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
Anticancer Drugs
; 35(1): 63-69, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067996
2.
MicroRNA and long non-coding RNA analysis in IgM monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesis.
Haematologica
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058213
3.
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
Am J Hematol
; 98(3): 432-439, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588384
4.
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma.
Blood
; 136(21): 2401-2409, 2020 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730586
5.
Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemia.
Am J Hematol
; 96(8): 945-953, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909933
6.
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma.
Blood
; 132(21): 2240-2248, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262659
7.
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial.
Blood
; 131(2): 182-190, 2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29074501
8.
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma.
Blood
; 130(10): 1198-1204, 2017 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28684537
9.
Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib.
Blood
; 128(20): 2415-2422, 2016 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27702799
10.
Necrobiotic xanthogranuloma: a 30-year single-center experience.
Ann Hematol
; 97(8): 1471-1479, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29568990
11.
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients.
Ann Hematol
; 97(8): 1453-1462, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29623394
12.
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.
Ann Hematol
; 97(8): 1417-1425, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29610969
13.
Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta-analysis.
Am J Hematol
; 93(10): 1220-1226, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30033656
14.
MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia.
Am J Hematol
; 93(2): 187-194, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29080258
15.
Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.
Br J Haematol
; 179(1): 98-105, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28786474
16.
The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma.
Blood
; 126(3): 328-35, 2015 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25921059
17.
Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.
Am J Hematol
; 92(5): 448-453, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28211162
18.
Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.
Am J Hematol
; 92(8): 759-763, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28402581
19.
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.
Am J Hematol
; 92(5): 467-472, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28230270
20.
Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma.
Blood
; 124(7): 1047-55, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24904120